Access cutting-edge atopic dermatitis treatment through this clinical trial at a research site in Atlanta. Study-provided care at no cost to qualified participants.
Access atopic dermatitis specialists in Atlanta at no cost
This study follows strict safety protocols and ethical guidelines
All study-related atopic dermatitis treatment provided free
The purpose of this study is to assess the efficacy and safety of Afimkibart (also known as RO7790121) in participants with moderate to severe atopic dermatitis (AD).
Sponsor: Hoffmann-La Roche
Check if you qualify for this atopic dermatitis clinical trial in Atlanta, GA
If you're searching for atopic dermatitis treatment options in Atlanta, GA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Atlanta research site is actively enrolling participants for this clinical trial. You'll receive care from experienced atopic dermatitis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.